Cytochrome-P450-Dependent Biotransformation of Xenobiotics in Human and Rodent Embryonic Tissues

References

• Shepard T. H. Catalog of Teratogenic Agents, 8th ed. Johns Hopkins University Press, Baltimore, MD 1995
   Google Scholar
• Done A. K. Developmental pharmacology. Clin. Pharmacol. Therap. 1964; 5: 432–479
   PubMed Web of Science ®Google Scholar
• Done A. K. Perinatal pharmacology. Annu. Rev. Pharmacol. 1966; 6: 189–208
   PubMedGoogle Scholar
• Rane A., Sjoqvist F., Orrenius S. Drugs and fetal metabolism. Clin. Pharmacol. Therap. 1973; 14: 666–672
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Karki N. T. Drug metabolism in human fetal tissues. Life Sci. 1973; 13: 1163–1180
   Web of Science ®Google Scholar
• Juchau M. R. Metabolic capabilities of the human fetus: drug biotransformation. Int. J. Addict. Dis. 1975; 2: 37–43
   PubMedGoogle Scholar
• Pelkonen O. Transplacental transfer of foreign compounds and their metabolism by the fetus. Prog. Drug Metab. 1977; 2: 119–161
   Google Scholar
• Waddell W. J., Marlowe G. C. Disposition of drugs in the fetus. Perinatal Pharmacology and Therapeutics, B. L. Mirkin. Academic Press, New York 1976
   Google Scholar
• Juchau M. R., Chao S. T., Omiecinski C. J. Drug metabolism by the human fetus. Clin. Pharmacokinet. 1980; 5: 320–340
   PubMed Web of Science ®Google Scholar
• Jondorf W. K., Maickel R. P., Brodie B. B. Inability of newborn mice and guinea pigs to metabolize drugs. Biochem. Pharmacol. 1958; 1: 352–354
   Web of Science ®Google Scholar
• Fouts J. R., Adamson R. H. Drug metabolism in the newborn rabbit. Science 1959; 129: 897–898
   PubMed Web of Science ®Google Scholar
• Brown A. K., Suelzer W. W. Studies on the neonatal development of the glucuronide conjugating system. J. Clin. Invest. 1958; 37: 332–340
   PubMed Web of Science ®Google Scholar
• Hart L. G., Adamson R. H., Dixon R. L., Fouts J. R. Stimulation of hepatic microsomal drug metabolism in the newborn and fetal rabbit. J. Pharmacol. Exp. Therap. 1962; 137: 103–106
   PubMed Web of Science ®Google Scholar
• Bogdan D. P., Juchau M. R. Characteristics of induced benzopyrene hydroxylase in the rat foeto-placental unit. Eur. J. Pharmacol. 1970; 10: 119–126
   PubMed Web of Science ®Google Scholar
• Yaffe S. J., Rane A., Sjoqvist F., Boreus O., Orrenius S. The presence of a monooxygenase system in human fetal liver microsomes. Life Sci. 1970; 9: 1189–1200
   Web of Science ®Google Scholar
• Juchau M. R., Lee Q. P., Louviaux G. L., Symms K. G., Krasner J., Yaffe S. J. Oxidation and reduction of foreign compounds in tissues of the human placenta and fetus. Fetal Pharmacology, L. Boreus. Raven Press, New York 1973
   Google Scholar
• Yaffe S. J., Juchau M. R. Perinatal pharmacology. Annu. Rev. Pharmacol. 1974; 14: 219–238
   Google Scholar
• Juchau M. R., Namkung M. J., Berry D. L., Zachariah P. K. Oxidative biotransformation of 2-acetylaminofluorene in fetal and placental tissues of humans and monkeys: correlations with arylhydrocarbon hydroxylase activities. Drug Metab. Disp. 1975; 3: 494–502
   Web of Science ®Google Scholar
• Juchau M. R., Berry D. L., Zachariah P. K., Namkung M. J., Slaga T. J. Prenatal biotransformation of benzo(a)pyrene and N-2-fluorenylacetamide in human and subhuman primates. Carcinogenesis (Vol. 1, Polynuclear Aromatic Hydrocarbons), R. Freudenthal, P. W. Jones. Raven Press, New York 1976
   Google Scholar
• Berry D. L., Zachariah P. K., Namkung M. J., Juchau M. R. Transplacental induction of carcinogen hydroxylating systems with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Appl. Pharmacol. 1976; 36: 569–584
   PubMed Web of Science ®Google Scholar
• Berry D. L., Slaga T. J., Wilson N. M., Zachariah P. K., Namkung M. J., Bracken W. R., Juchau M. R. Transplacental induction of mixed-function oxygenases in extra-hepatic tissues by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Biochem. Pharmacol. 1977; 26: 1383–1388
   PubMed Web of Science ®Google Scholar
• Berry D. L., Zachariah P. K., Slaga T. J., Juchau M. R. Analysis of the biotransformation of benzo(a)pyrene in human fetal and placental tissues with high pressure liquid chromatography. Eur. J. Cancer 1977; 13: 667–675
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Pedersen M. G. Drug biotransformation reactions in the human fetal adrenal gland. Life Sci. II—Biochem. Gen. Molec. Biol. 1973; 12: 193–204
   Web of Science ®Google Scholar
• Zachariah P. K., Juchau M. R. Spectral characteristics of human fetal adrenal microsomes. Life Sci. 1975; 16: 55–63
   PubMed Web of Science ®Google Scholar
• Jones A. H., Fantel A. G., Kocan R. M., Juchau M. R. Bioactivation of procarcinogens to mutagens in human fetal and placental tissues. Life Sci. 1977; 21: 1831–1837
   PubMed Web of Science ®Google Scholar
• Pelkonen O. Fetoplacental biochemistry—xenobiotic metabolism and pharmacokinetics. Occupational Hazards and Reproduction, K. Hemminki, M. Sorsa, H. Vainio. Hemisphere Publishing, Washington, DC 1985
   Google Scholar
• Anderson L. M., Jones A. B., Miller M. S., Chauhan D. P. Metabolism of transplacaental carcinogens. Transplacental and Multigeneration Carcinogenesis, N. P. Napalkov, J. M. Rice, L. Tomatis, H. Yamasaki. IARC Scientific Publications, London 1989
   Google Scholar
• Juchau M. R., Harris C., Beyer B. K., Fantel A. G. Reactive intermediates in chemical teratogenesis. Approaches to Elucidate Mechanisms in Teratogenesis, F. Welsch. Hemisphere Publishing, New York 1987
   Google Scholar
• Juchau M. R. Bioactivation in chemical teratogenesis. Annu. Rev. Pharmacol. Toxicol. 1989; 29: 165–187
   PubMed Web of Science ®Google Scholar
• Juchau M. R. Developmental drug metabolism. Comprehensive Medicinal Chemistry: Vol. 5, Biopharmaceutics, C. Hansch. Pergamon Press, New York 1990
   Google Scholar
• Juchau M. R., Harris C., Stark K. L., Lee Q. P., Yang H. L., Namkung M. J., Fantel A. G. Cytochrome P450-dependent bioactivation of prodysmorphogens in cultured conceptuses. Reprod. Toxicol. 1991; 5: 259–264
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Lee Q. P., Fantel A. G. Xenobiotic biotransformation/ bioactivation in organogenesis-stage conceptal tissues: implications for embryotoxicity and teratogenesis. Drug Metab. Rev. 1992; 24: 195–238
   PubMed Web of Science ®Google Scholar
• Nebert D. W. The Ah locus: genetic differences in toxicity, cancer, mutation and birth defects. Crit. Rev. Toxicol. 1989; 20: 153–174
   PubMed Web of Science ®Google Scholar
• Krauer B., Dayer P. Fetal drug metabolism and its possible clinical implications. Clin. Pharmacokinet. 1991; 21: 70–80
   PubMed Web of Science ®Google Scholar
• Wells P. G., Kim P. M., Nicol C. J., Parman T., Winn L. M. Reactive intermediates. Handbook of Experimental Pharmacology and Drug Toxicity in Embryonic Development, R. J. Kavlock, G. P. Daston. Springer-Verlag, Heidelberg 1996
   Google Scholar
• Wells P. G., Winn L. M. Biochemical toxicology of chemical teratogenesis. Crit. Rev. Biochem. Molec. Biol. 1996; 31: 1–40
   PubMed Web of Science ®Google Scholar
• Wells P. G., Winn L. M. The role of biotransformation in developmental toxicology. Comprehensive Toxicology, Vol. 10, Section 3, Developmental Toxicology, C. Harris. Pergamon/Elsevier Science Ltd., Amsterdam 1997
   Google Scholar
• Raucy J. L., Carpenter S. J. The expression of xenobiotic metabolizing cytochromes P450 in fetal tissues. J. Pharmacol. Toxicol. Methods 1993; 29: 121–128
   PubMed Web of Science ®Google Scholar
• Miller M. S., Juchau M. R., Guengerich F. P., Nebert D. W., Raucy J. L. Drug metabolic enzymes in developmental toxicology. Fundam. Appl. Toxicol. 1996; 34: 165–176
   PubMedGoogle Scholar
• Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: 1–42
   PubMedGoogle Scholar
• Shimada T., Yamazaki H., Mimura M., Wakamiya N., Ueng Y., Guengerich F. P., Inui Y. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs. Drug Metab. Disp. 1996; 24: 515–522
   PubMed Web of Science ®Google Scholar
• Shimada T., Hayes C. L., Yamazaki H., Amin S., Hecht S. S., Guengerich F. P., Sutter T. R. Activation of chemically diverse procarcinogens by human cytochrome P4501B1. Cancer Res. 1996; 56: 2979–2986
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Shimada T., Yamazaki H., Mimura M. Comparison of cytochrome P450 enzymes and their activities in human fetal and adult liver. Fundam. Appl. Toxicol. 1996; 34: 168–172
   Google Scholar
• Kaminsky G. S., Dannan G. A., Guengerich F. P. Composition of cytochrome P450 isozymes from hepatic microsomes of C57BL/6 and DBA/2 mice assessed by warfarin metabolism, immunoinhibition and immunoelectrophoresis with anti-(rat) cytochrome P450. Eur. J. Biochem. 1984; 141: 141–148
   PubMedGoogle Scholar
• Yang H. Y. L., Namkung M. J., Juchau M. R. Cytochrome P450-dependent biotransformation of a series of phenoxazone ethers in the rat conceptus during early organogenesis: evidence for multiple P450 isoenzymes. Molec. Pharmacol. 1988; 34: 67–74
   PubMed Web of Science ®Google Scholar
• Namkung M. J., Yang H. L., Juchau M. R. Cytochrome P450-dependent biotransformation of 2-acetylaminofluorene in cell-free preparations of human embryonic hepatic, adrenal, renal, pulmonary and cardiac tissues. Drug Metab. Disp. 1994; 22: 331–338
   PubMed Web of Science ®Google Scholar
• Chapman D. E., Yang H. L., Watters J., Juchau M. R. Induction in vitro and complete coding region sequence of cytochrome P4501 A1 cDNA from cultured whole rat conceptuses during early organogenesis. Biochem. Pharmacol. 1994; 48: 1807–1814
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Chapman D. E., Yang H. L., Lee Q. P., Namkung M. J., Hinds T. R. Catalysis of the dealkylation/debenzylation of phenoxazone ethers by hemoglobin in the absence of peroxides: implications for investigations of embryonic biotransformation. Drug Metab. Disp. 1996; 24: 1362–1369
   PubMed Web of Science ®Google Scholar
• Omiecinski C. J., Chao S. T., Juchau M. R. Modulation of monooxygenase activities by hematin and 7,8-benzoflavone in fetal tissues of rats, rabbits and humans. Dev. Pharmacol. Therap. 1980; 1: 90–100
   PubMedGoogle Scholar
• Namkung M. J., Faustman-Watts E. M., Juchau M. R. Hematin-mediated increases of benzo(a)pyrene monooxygenation in maternal, fetal and placental tissues of inducible and non-inducible mouse strains. Dev. Pharmacol. Therap. 1983; 6: 199–207
   PubMedGoogle Scholar
• Namkung M. J., Porubek D. H., Nelson S. D., Juchau M. R. Regulation of aromatic oxidation of estradiol-17β in maternal hepatic, fetal hepatic and placental tissues: comparative effects of a series of inducing agents. J. Steroid Biochem. 1985; 22: 563–568
   PubMedGoogle Scholar
• Yang H. L., Namkung M. J., Juchau M. R. Immunodetection, immunoinhibition, immunoquantitation and biochemical analyses of cytochrome P4501 A1 in tissues of the rat conceptus during the progression of organogenesis. Biochem. Pharmacol. 1989; 38: 4027–4037
   PubMed Web of Science ®Google Scholar
• Yang H. L., Zelus B. D., Juchau M. R. Organogenesis-stage cytochrome P450 isoforms: utilization of PCR for detection of CYPIAI mRNA in rat conceptal tissues. Biochem. Biophys. Res. Commun. 1991; 178: 236–241
   PubMed Web of Science ®Google Scholar
• Yang H. L., Namkung M. J., Juchau M. R. Expression of functional cytochrome P4501 A1 in human embryonic hepatic tissues during organogenesis. Biochem. Pharmacol. 1995; 49: 717–726
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Yang H. L. Cytochrome P450-dependent monooxgenation of embryotoxic/teratogenic chemicals in human embryonic tissues. Fundam. Appl. Toxicol. 1996; 34: 166–168
   Google Scholar
• Omiecinski C. J., Redlich C. A., Costa P. Induction and developmental expression of cytochrome P4501 A1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Res. 1990; 50: 4315–4321
   PubMed Web of Science ®Google Scholar
• Murray G. I., Foster C. O., Barnes T. S., Weaver R. J., Snyder C. P., Ewen S. W. B., Melvin W. T., Burke M. D. Cytochrome P4501 A expression in adult and human fetal liver. Carcinogenesis 1992; 13: 165–169
   PubMed Web of Science ®Google Scholar
• Abbott B. D., Birnbaum L. S., Perdew G. H. Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. Dev. Dynam. 1995; 204: 133–139
   PubMed Web of Science ®Google Scholar
• Galloway S. M., Perry P. E., Meneses J., Nebert D. W., Pedersen R. A. Cultured mouse embryos metabolize benzo(a)pyrene during early gestation: genetic differences detectable by sister chromatid exchange. Proc. Natl. Acad. Sci. USA 1980; 77: 3524–3528
   PubMed Web of Science ®Google Scholar
• Filler R., Lew K. J. Developmental onset of mixed-function oxidase activity in preimplantation mouse embryos. Proc. Natl. Acad. Sci. USA 1981; 78: 6991–6995
   PubMed Web of Science ®Google Scholar
• Pedersen R. A., Meneses J., Spindle A., Wu K., Galloway S. M. Cytochrome P450 metabolic activity in embryonic and extraembryonic tissue lineages of mouse embryos. Proc. Natl. Acad. Sci. USA 1985; 82: 3311–3315
   PubMed Web of Science ®Google Scholar
• Dey A., Westphal H., Nebert D. W. Cell-specific induction of mouse Cyplal mRNA during development. Proc. Natl. Acad. Sci. USA 1989; 86: 7446–7450
   PubMed Web of Science ®Google Scholar
• Lee Q. P., Fantel A. G., Juchau M. R. Human embryonic cytochrome P450s: phenoxazone ethers as probes for expression of functional isoforms during organogenesis. Biochem. Pharmacol. 1991; 42: 2377–2386
   PubMed Web of Science ®Google Scholar
• Lee Q. P., Yang H. L., Namkung M. J., Juchau M. R. cAMP-dependent regulation of P450-catalyzed dealkylation in rat conceptal tissues. Reprod. Toxicol. 1991; 5: 473–481
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Huang Y., Boutelet-Bochan H., Yang H. L. Expression of P450 cytochromes in human and rodent embryonic tissues during the period of organogenesis: implications for teratogenesis. Abstracts of the Eleventh International Symposium on Microsomes and Drug Oxidations. 1996; 246
   Google Scholar
• Huang Y., Yang H. L., Juchau M. R. Identification of TCDD-responsive changes in P450 gene expression in human liver explants using differential display. Toxicologist 1996; 30: 197
   Google Scholar
• Miller M. S., Wessner L. L., Fan M., Mc Entee M. F., Schaeffer D. O. Frequent mutations in KI-ras in mouse lung tumors following transplacental exposure to 3-methylcholanthrene. Fundam. Appl. Toxicol. 1996; 34: 165–175
   PubMedGoogle Scholar
• Carpenter S. P., Lasker J. M., Raucy J. L. Expression, induction and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver. Molec. Pharmacol. 1996; 49: 260–268
   PubMed Web of Science ®Google Scholar
• Wrighton S. A., Molowa D. T., Guzelian P. S. Identification of a cytochrome P450 in human fetal liver related to glucocorticoid-inducible cytochrome P450HLp in the adult. Biochem. Phannacol. 1988; 37: 3053–3055
   PubMed Web of Science ®Google Scholar
• Jones S. M., Boobis A. R., Moore G. E., Stanier P. M. Expression of CYP2E1 during human fetal development: methylation of the CYP2E1 gene in human and fetal adult liver samples. Biochem. Pharmacol. 1992; 43: 1876–1880
   PubMed Web of Science ®Google Scholar
• Vieira I., Sonnier M., Cresteil T. Developmental expression of CYP2E1 in the human liver: hypermethylation control of gene expression during the neonatal period. Eur. J. Biochem. 1996; 238: 476–483
   PubMedGoogle Scholar
• Wu D., Cederbaum A. I. Expression of cytochrome P4502E1 in rat fetal hepatocyte culture. Molec. Pharmacol. 1996; 49: 802–807
   PubMed Web of Science ®Google Scholar
• Lee Q. P., Juchau M. R. Mechanisms of glucagon-induced increases in rates of cytochrome P450-dependent pentoxyphenoxazone O-depentylation in cultured rat conceptuses. Reprod. Toxicol. 1992; 6: 525–533
   PubMed Web of Science ®Google Scholar
• Lubet R. A., Mayer R. T., Cameron J. W., Nims R. W., Burke M. D., Wolff T., Guengerich F. P. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys. 1985; 238: 43–48
   PubMed Web of Science ®Google Scholar
• Borlakoglu J. T., Scott A., Henderson C. J., Wolf C. R. Expression of P450 isoenzymes during rat liver organogenesis. Int. J. Biochem. 1993; 25: 1659–1668
   PubMedGoogle Scholar
• Cresteil T., Beaune P., Kremers P., Flinois J., Leroux J. Drug metabolizing enzymes in human foetal liver: partial resolution of multiple cytochromes P450. Pediatr. Pharmacol. 1982; 2: 199–207
   PubMedGoogle Scholar
• Treluyer J-M., Jacqz-Aigrain E., Alvarez F., Cresteil T. Expression of CYP2D6 in developing human liver. Eur. J. Biochem. 1991; 202: 583–588
   PubMedGoogle Scholar
• Maenpaa J., Rane A., Raunio H., Honkakoski P., Pelkonen O. Cytochrome P450 isoforms in human fetal tissues related to phenobarbital-inducible forms in the mouse. Biochem. Pharmacol. 1993; 45: 899–907
   PubMed Web of Science ®Google Scholar
• Hakkola J., Pasanen M., Purkunen R., Saarikoski S., Pelkonen O., Maenpaa J., Rane A., Raunio H. Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem. Pharmacol. 1994; 48: 59–64
   PubMed Web of Science ®Google Scholar
• Kitada M., Taneda M., Itahashi K., Kamataki T. Four forms of cytochrome P450 in human fetal liver: purification and their capacity to activate promutagens. Jpn. J. Cancer Res. 1991; 82: 426–432
   PubMedGoogle Scholar
• Wrighton S. A., Vandenbranden M. Isolation and characterization of human fetal liver cytochrome P450HLp2: a third member of the P450III gene family. Arch. Biochem. Biophys. 1989; 268: 144–151
   PubMed Web of Science ®Google Scholar
• Kitada M., Kamataki T. Cytochrome P450 in human fetal liver: significance and fetal-specific expression. Drug Metab. Rev. 1994; 26: 305–323
   PubMed Web of Science ®Google Scholar
• Schuetz J. D., Beach D. L., Guzelian P. S. Selective expression of cytochrome P4503A mRNAs in embryonic and adult human liver. Pharmacogenetics 1994; 4: 11–20
   PubMedGoogle Scholar
• Li Y., Yokoi T., Kitamura R., Sasaki M., Gunji M., Katsuki M., Kamataki T. Establishment of transgenic mice carrying human fetus-specific CYP3A7. Arch. Biochem. Biophys. 1996; 329: 235–240
   PubMed Web of Science ®Google Scholar
• Hulla J. E., Juchau M. R. Developmental aspects of P450IIIA: prenatal activity and inducibility. Drug Metab. Rev. 1989; 20: 765–781
   PubMed Web of Science ®Google Scholar
• Huila J. E., Juchau M. R. Occurrence and inducibility of cytochrome P450IIIA in maternal and fetal rats during prenatal development. Biochemistry 1989; 28: 4871–4880
   PubMed Web of Science ®Google Scholar
• Yang H. L., Lee Q. P., Rettie A. E., Juchau M. R. Functional CYP3A isoforms in human embryonic tissues: expression during organogenesis. Molec. Pharmacol. 1994; 46: 922–929
   PubMed Web of Science ®Google Scholar
• Paine M. F., Shen D. D., Kunze K. L., Perkins J. D., Marsh C. L., Mc Vicar J. P., Barr D. M., Gillies B. S., Thummel K. E. First pass metabolism of midazolam by the human intestine. Clin. Pharmacol. Therap. 1996; 60: 14–25
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Namkung M. J., Jones A. H., Di Giovanni J. Biotransformation and bioactivation of 7,12-dimethylbenz(a)anthracene in human fetal and placental tissues. Drug Metab. Disp. 1978; 6: 273–281
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Di Giovanni J., Namkung M. J., Jones A. H. A comparison of the capacity of fetal and adult liver, lung and brain to convert polycyclic aromatic hydrocarbons to mutagenic and cytotoxic metabolites in mice and rats. Toxicol. Appl. Pharmacol. 1979; 49: 171–178
   PubMed Web of Science ®Google Scholar
• Juchau M. R. Enzymatic bioactivation and inactivation of chemical teratogens and transplacental carcinogens and mutagens. The Biochemical Basis of Chemical Teratogenesis, M. R. Juchau. Elsevier, New York 1981
   Google Scholar
• Juchau M. R. Biotransformation of environmental chemicals in the human fetus and trophoblast. Placenta: A Model for Toxicology, R. Beaconsfield, G. Birdwood. Pergamon Press, New York 1982
   Google Scholar
• Rettie A. E., Rettenmeier A. W., Beyer B. K., Baillie T. A., Juchau M. R. Valproate hydroxylation by human fetal tissues and embryotoxicity of metabolites. Clin. Pharmacol. Therap. 1986; 40: 172–178
   PubMed Web of Science ®Google Scholar
• Bond J. A., Kocan R. M., Benditt E. P., Juchau M. R. Metabolism of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene in cultured human fetal aortic cells. Life Sci. 1979; 25: 425–430
   PubMed Web of Science ®Google Scholar
• Bond J. A., Kocan R. M., Benditt E. P., Juchau M. R. Oxidative and nonoxidative metabolism of polycyclic aromatic hydrocarbons in rabbit and chicken aortas and in human fetal smooth-muscle cells. Polynuclear Aromatic Hydrocarbons: Chemistry and Biological Effects, A. Bjorseth, A. J. Dennis. Battelle Press, Columbus, OH 1980
   Google Scholar
• Majesky M. W., Reidy M. A., Benditt E. P., Juchau M. R. Focal smooth muscle hyperplasia in the aortic intima produced by an initiation-promotion sequence. Proc. Natl. Acad. Sci. USA 1985; 82: 3450–3455
   PubMed Web of Science ®Google Scholar
• De Flora S., Izzotti A., Randerath K., Randerath E., Bartsch H., Nair J., Balansky R., van Schooten F., Degan P., Fronza G., Walsh D., Lewtas J. DNA adducts and chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine. Mutagen. Res. 1996; 366: 197–238
   PubMed Web of Science ®Google Scholar
• Wessner L. L., Fan M., Schaeffer D. O., Mc Entee M. F., Miller M. S. Induction of activating gene mutations at the Ki-ras-locus following trans-placental exposure of mice to 3-methylcholanthrene. Carcinogenesis 1996; 7: 1519–1526
   Google Scholar
• Faustman-Watts E., Greenaway J. C., Namkung M. J., Fantel A. G., Juchau M. R. Teratogenicity in vitro of 2-acetylaminofluorene: role of biotransformation. Teratology 1983; 27: 19–29
   PubMedGoogle Scholar
• Faustman-Watts E. M., Giachelli C. M., Juchau M. R. Carbon monoxide inhibits embryonic monooxygenation and embryotoxic effects of proteratogens in vitro. Toxicol. Appl. Pharmacol. 1986; 83: 590–596
   PubMed Web of Science ®Google Scholar
• Faustman-Watts E. M., Namkung M. J., Greenaway J. C., Juchau M. R. Analyses of metabolites of 2-acetylaminofluorene generated in an embryo culture system: relationship of biotransformation to teratogenicity in vitro. Biochem. Pharmacol. 1985; 34: 2953–2960
   PubMed Web of Science ®Google Scholar
• Faustman-Watts E. M., Yang H. Y. L., Namkung M. J., Greenaway J. C., Fantel A. G., Juchau M. R. Mutagenic, cytotoxic and teratogenic effects of 2-acetylaminofluorene and reactive metabolites in vitro. Teratogen. Carcinogen. Mutagen. 1984; 4: 273–283
   PubMedGoogle Scholar
• Juchau M. R., Giachelli C. M., Fantel A. G., Greenaway J. C., Shepard T. H., Faustman-Watts E. M. Effects of 3-methylcholanthrene and phenobarbital on the capacity of embryos to bioactivate teratogens during organogenesis. Toxicol. Appl. Pharmacol. 1985; 80: 137–147
   PubMed Web of Science ®Google Scholar
• Juchau M. R., Bark D. H., Shewey L. M., Greenaway J. C. Generation of reactive dysmorphogenic intermediates by rat embryos in culture: effects of cytochrome P450 inducers. Toxicol. Appl. Pharmacol. 1985; 81: 533–544
   PubMed Web of Science ®Google Scholar
• Fantel A. G., Greenaway J. C., Juchau M. R., Shepard T. H. Teratogenic bioactivation of cyclophosphamide in vitro. Life Sci. 1979; 25: 67–72
   PubMed Web of Science ®Google Scholar
• Greenaway J. C., Fantel A. G., Shepard T. H., Juchau M. R. The in vitro teratogenicity of cyclophosphamide in rat embryos. Teratology 1982; 25: 335–344
   PubMedGoogle Scholar
• Juchau M. R., Faustman-Watts E. Pharmacokinetic considerations in the maternal-placental-fetal unit. Clin. Obstet. Gynecol. 1983; 26: 379–390
   PubMedGoogle Scholar
• Fantel A. G., Person R. E., Juchau M. R. Niridazole metabolism by rat embryos in vitro. Teratology 1988; 37: 213–223
   PubMedGoogle Scholar
• Fantel A. G., Juchau M. R., Burroughs C. J., Person R. E. Studies of embryotoxic mechanisms of niridazole: evidence that oxygen depletion plays a role in dysmorphogenicity. Teratology 1989; 39: 243–253
   PubMedGoogle Scholar
• Chao S. T., Omiecinski C. J., Namkung M. J., Nelson S. D., Dvorchik B. H., Juchau M. R. Catechol estrogen formation in placental and fetal tissues of humans, macaques, rats and rabbits. Dev. Pharmacol. Therap. 1981; 2: 1–17
   PubMedGoogle Scholar
• Beyer B. K., Juchau M. R. Conversion of estradiol-17β to reactive embryotoxic intermediates by cytochrome P450-dependent bioactivating systems. Biochem. Biophys. Res. Commun. 1987; 145: 402–408
   PubMed Web of Science ®Google Scholar
• Beyer B. K., Stark K. L., Fantel A. G., Juchau M. R. Biotransformation, estrogenicity and steroid structure as determinants of dysmorphogenic and generalized embryotoxic effects of steroidal and nonsteroidal estrogens. Toxicol. Appl. Pharmacol. 1989; 98: 113–128
   PubMed Web of Science ®Google Scholar
• Stark K. L., Harris C., Juchau M. R. Influence of electrophilic character and glutathione depletion on chemical dysmorphogenesis in cultured rat embryos. Biochem. Pharmacol. 1989; 38: 2685–2693
   PubMed Web of Science ®Google Scholar
• Stark K. L., Lee Q. P., Namkung M. J., Harris C., Juchau M. R. Dysmorphogenesis elicited by microinjected acetaminophen analogues and metabolites in rat embryos cultured in vitro. J. Pharmacol. Exp. Therap. 1990; 255: 74–83
   PubMed Web of Science ®Google Scholar
• Harris C., Stark K. L., Luchtel D. L., Juchau M. R. Abnormal neurulation induced by 7-hydroxy-2-acetylaminofluorene and acetaminophen: evidence for catechol metabolites as proximate dysmorphogens. Toxicol. Appl. Pharmacol. 1989; 101: 432–437
   PubMed Web of Science ®Google Scholar
• Chapman D. E., Namkung M. J., Juchau M. R. Benzene and benzene metabolites as embryotoxic agents: effects on cultured rat embryos. Toxicol. Appl. Pharmacol. 1994; 128: 129–138
   PubMed Web of Science ®Google Scholar
• Creech Kraft J. M., Juchau M. R. Conceptual biotransformation of microinjected retinoids: correlations with dysmorphogenic activities. Ann. NY Acad. Sci. 1993; 678: 338–341
   PubMed Web of Science ®Google Scholar
• Juchau M. R. Chemical teratogenesis. Prog. Drug Res. 1993; 41: 9–51
   PubMedGoogle Scholar
• Juchau M. R. Chemical teratogenesis in humans: biochemical and molecular mechanisms. Prog. Drug Res. 1997; 49: 25–92
   PubMedGoogle Scholar
• Rogers J. M., Kavlock R. J. Developmental toxicology. Casaraett & Doull's Toxicology: The Basic Science of Poisons, 5th ed., C. D. Klaassen. McGraw-Hill, New York 1996
   Google Scholar